2011 Annual Meeting | Management of Spasticity

Date Friday 04/27/12

Time 08:00 AM - 12:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type AM Half-Day Course

Director(s) Allison Brashear, MD, MBA, FAAN

Topic(s) Movement Disorders

Learning Objectives Participants should be able to select an appropriate patient for botulinum toxin treatment, select muscles, doses, and follow-up regimen; select the appropriate patient for ITB therapy and understand the risks, benefits, and indication for this therapy; understand the role of oral medication and therapy in the treatment of spasticity; and fully appreciate the complexity of the different presentations and course of patients with spasticity.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Systems-based Practice

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Case-based, Interactive, Audience Participation

Event Timeline
08:00 AM - 08:15 AM		Introduction: Spasticity Case Management Allison Brashear, MD, MBA, FAAN
08:15 AM - 08:45 AM		Case I: Clenched Hand–What and How to Treat Allison Brashear, MD, MBA, FAAN
08:45 AM - 09:15 AM		Case 2: Spasticity Treatment in the Upper Arm/Shoulder Christina Marciniak, MD
09:15 AM - 09:45 AM		Case 3: Lower Extremity Spasticity Allison Brashear, MD, MBA, FAAN
09:45 AM - 10:15 AM		Case 4: Lower Extermity Spasticity–Combining Therapies P. D. Charles, MD, FAAN
10:15 AM - 10:30 AM		Break
10:30 AM - 11:00 AM		Case 5: Generalized Spasticity–Combining Treatments P. D. Charles, MD, FAAN
11:00 AM - 11:30 AM		Refractory Spasticity: Combining Surgery with ITB/BoNT Christina Marciniak, MD
11:30 AM - 12:00 PM		Discussion

Faculty Disclosures
Allison Brashear, MD, MBA, FAAN	Dr. Brashear has received personal compensation for serving as an employee of McKnight Brain Res Found. Dr. Brashear has received personal compensation for serving as an employee of American Board of Psychiatry and Neurology. Dr. Brashear has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN. Dr. Brashear has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for McKnight Brain Research Foundation i. Dr. Brashear has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Care Directions- start up . Dr. Brashear has stock in Caredirections . The institution of Dr. Brashear has received research support from NINDS. Dr. Brashear has received publishing royalties from a publication relating to health care. Dr. Brashear has received personal compensation in the range of $500-$4,999 for serving as a Special government employee and study section reviewer with NIH. Dr. Brashear has received personal compensation in the range of $0-$499 for serving as a Adminstrative board -travel reimbursement with AAMC.
P. D. Charles, MD, FAAN	Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Iota. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceraxis. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aspen Neuroscience. Dr. Charles has stock in Arena Therapeutics. The institution of Dr. Charles has received research support from Pharma 2 B. The institution of Dr. Charles has received research support from Intec. The institution of Dr. Charles has received research support from Merz. The institution of Dr. Charles has received research support from Novartis. The institution of Dr. Charles has received research support from Aeon. The institution of Dr. Charles has received research support from Impax. The institution of Dr. Charles has received research support from AskBio. The institution of Dr. Charles has received research support from BlueRock. The institution of Dr. Charles has received research support from AbbVie. The institution of Dr. Charles has received research support from Ipsen.
Christina Marciniak, MD	No disclosure on file

��ɫ��

��ɫ��